LIMS2 (LIM zinc finger domain containing 2) functions as an adapter protein that links beta-integrins to the actin cytoskeleton and bridges cellular complexes to receptor tyrosine kinases, playing a crucial role in cell spreading and migration 1. The protein is part of the integrin-linked kinase (ILK)-LIMS-parvin complex at focal adhesions, where it regulates cell adhesion and motility 2. LIMS2 expression is frequently silenced through CpG island hypermethylation in various cancers, including gastric cancer (91% of cell lines) and cervical cancer, where its loss promotes tumor cell migration and progression 13. The gene serves as a tumor suppressor, with restoration of expression inhibiting cancer cell migration 1. LIMS2 mutations cause a severe autosomal recessive muscular dystrophy characterized by childhood-onset weakness progressing to quadriparesis, biventricular cardiac dysfunction, and distinctive triangular tongues 2. In bladder cancer, LIMS2 downregulation is associated with immune dysregulation and poor prognosis 4. The protein's role in apoptosis regulation is evidenced by its upregulation following heparanase silencing in melanoma cells 5. These findings establish LIMS2 as both a critical regulator of cell-matrix interactions and a potential therapeutic target in cancer and muscular dystrophy.